An interventional study of Workshop and consultation for caregivers of at risk youth in Caregivers, Suicide and Nonsuicidal Self Injury, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by University of California, San Francisco · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 387 studies in Suicide with a site in United States — 100 open to participants now, 114 under way, 2 of them phase 3. Suicide · United States.
Among the 387 studies in Suicide with a site in United States, this one is the 216th largest by planned enrollment of the 349 interventional ones that give a count, is one of 32 that started in 2026, is one of 289 with no phase, reaches primary completion later than 74 of the 113 other live ones, and was the 383rd registered.
609 studies on the registry are indexed under Suicide; 163 are open to participants now.
Browse Suicide studies →100 of the 387 studies in Suicide with a site in United States are open now. Recruiting first, the newest first:
Columbia University · Sites in United States
Ages 12–80
Albert Einstein College of Medicine · Sites in United States
Ages 14–18
University of California, San Diego · Sites in United States
Ages 12–30
VA Office of Research and Development · Sites in United States
Ages 18+
University of Pennsylvania · Sites in United States
Ages 13–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 114 Suicide studies recruiting now, 55 (48%) set no upper age limit and 56 (49%) stop at 75 or younger; 52 take children under 18; 25 take healthy volunteers.
This study: 12 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
387 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 23 · Phase 2 30 · Phase 3 10 · Phase 4 11
First in 1990; this study’s year is marked. 32 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 104 across 492 interventional studies indexed under Suicide.
Median enrollment 91 across the 349 interventional studies, 172 across the 36 observational. Of the 251 that completed or were terminated, 103 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 387 have an industry lead sponsor. The 10 most frequent:
University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.
Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.
University of California, San Francisco has 1 study filed under Suicide — fewer than ten, so there is no comparison to draw.
44 of the studies in Suicide with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05696691Phase 3The University of Texas Health Science Center at San AntonioKetamine & Crisis Response Plan for Suicidal Ideation in the ED | 2026-12-31 |
| NCT05558332University of California, IrvineYouth Nominated Support Team | 2026-11 |
| NCT06470867VA Office of Research and DevelopmentRandomized Controlled Effectiveness Trial of VA S.A.V.E. | 2026-11-27 |
| NCT05897164Evidence-Based Practice Institute, Seattle, WAMobile Technology to Reduce Teen Substance Misuse | 2026-11-30 |
| NCT06460220Jennifer HughesSAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth | 2026-12 |
Add all 44 to your calendar (.ics) → With an account.
Among the 387 studies in Suicide with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this pilot clinical trial is to explore the feasibility and acceptability of implementing an intervention for caregivers in our health care system. The intervention is intended to provide information and consultation to caregivers of youth ages 12-26 years old who are at risk of self-harm (i.e., suicidal behaviors and/or nonsuicidal self-injury). The intervention is based on principles of Dialectical Behavior Therapy, an evidence-based intervention for youth who engage in suicidal behaviors and nonsuicidal self-injury. Acceptability will be assessed through questionnaires and qualitative feedback. Feasibility will be assessed by tracking the amount of clinician resources needed and how long it takes to identify caregivers who want to participate. A group of caregivers who have lived experience of having a child at risk for self-harm will form an advisory board. The board will review the study methods and data; their advice will guide next steps.
Caregiver Participants Inclusion Criteria:
Caregiver Participants Exclusion Criteria:
Youth Participants Inclusion Criteria:
Youth Participants Exclusion Criteria:
Behavioral: Workshop and consultation for caregivers of at risk youth
The caregiver intervention is provided via telehealth and uses principles and information adapted from Dialectical Behavior Therapy for Adolescents (DBT; Miller, Rathus, Linehan, 2007). It consists of 4 session, 90 minutes each, over a 4-week period. The information and actives during these sessions are intended to: (1) provide education about suicidal and self-injurious thoughts \& behaviors and effective interventions, (2) support caregivers to implement safety measures at home, (3) increase caregiver coping skills, and (4) teach caregivers skills to support youth behavior change. Caregivers who attend the sessions are encouraged to get consultation with the same provider outside of the sessions. Weekly "office hours" are scheduled and they can also make an ad hoc appointment. The consultation will be provided for up to 6 months following the sessions. Consultation is meant to help caregivers apply the information they learn in the sessions to their particular family situation.
Caregiver participant attendance rate
The number of workshop and consultation sessions that caregivers attend will be used as a measure of acceptability.
Time frame: enrollment to 6 month follow-up
Caregiver participant survey & interview completion rate
The number of surveys and interviews that caregivers complete will be a primary measure of feasibility and acceptability of study methods.
Time frame: enrollment to 6-month follow-up
Youth participant survey & interview completion rate
The number of surveys and interviews that youth participants complete will be a primary measure of feasibility and acceptability of study methods.
Time frame: enrollment to 6-month follow-up
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Apr 2028, 18 months later.
Of 310 non-industry interventional studies with no phase under Suicide, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 54. This study's planned 18 months is below that.
Counting every sponsor, half of 321 studies reached it within 30 months; a quarter within 15 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Francisco →